Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Medicinal Chemistry"
DOI: 10.2210/pdb6kof/pdb
Abstract: Indoleamine 2,3-dioxygenase (IDO1) inhibitors are speculated to be useful in cancer immunotherapy, but a phase III clinical trial of the most advanced IDO1 inhibitor, epacadostat, did not meet its primary end point and was abandoned.…
read more here.
Keywords:
indoleamine dioxygenase;
aromatic interactions;
sulfur aromatic;
unique sulfur ... See more keywords